KRMD PE Ratio & Valuation,Is KRMD Overvalued

KRMD Relative Valuation

KRMD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, KRMD is overvalued; if below, it's undervalued.

Historical Valuation

KORU Medical Systems Inc (KRMD) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -38.84. The fair price of KORU Medical Systems Inc (KRMD) is between NaN to NaN according to relative valuation methord.

Relative Value

Fair Zone

NaN-NaN

Current Price：5.51

Fair

-440.80

125.03

EV/EBITDA

KORU Medical Systems Inc. (KRMD) has a current EV/EBITDA of 125.03. The 5-year average EV/EBITDA is 13.51. The thresholds are as follows: Strongly Undervalued below -299.16, Undervalued between -299.16 and -142.82, Fairly Valued between 169.85 and -142.82, Overvalued between 169.85 and 326.18, and Strongly Overvalued above 326.18. The current Forward EV/EBITDA of 125.03 falls within the Historic Trend Line -Fairly Valued range.

-110.11

EV/EBIT

KORU Medical Systems Inc. (KRMD) has a current EV/EBIT of -110.11. The 5-year average EV/EBIT is -22.98. The thresholds are as follows: Strongly Undervalued below -66.44, Undervalued between -66.44 and -44.71, Fairly Valued between -1.26 and -44.71, Overvalued between -1.26 and 20.47, and Strongly Overvalued above 20.47. The current Forward EV/EBIT of -110.11 falls within the Strongly Undervalued range.

5.82

KORU Medical Systems Inc. (KRMD) has a current PS of 5.82. The 5-year average PS is 4.76. The thresholds are as follows: Strongly Undervalued below 1.45, Undervalued between 1.45 and 3.10, Fairly Valued between 6.41 and 3.10, Overvalued between 6.41 and 8.07, and Strongly Overvalued above 8.07. The current Forward PS of 5.82 falls within the Historic Trend Line -Fairly Valued range.

133.64

P/OCF

KORU Medical Systems Inc. (KRMD) has a current P/OCF of 133.64. The 5-year average P/OCF is 31.02. The thresholds are as follows: Strongly Undervalued below -174.63, Undervalued between -174.63 and -71.80, Fairly Valued between 133.85 and -71.80, Overvalued between 133.85 and 236.67, and Strongly Overvalued above 236.67. The current Forward P/OCF of 133.64 falls within the Historic Trend Line -Fairly Valued range.

222.73

P/FCF

KORU Medical Systems Inc. (KRMD) has a current P/FCF of 222.73. The 5-year average P/FCF is 5.47. The thresholds are as follows: Strongly Undervalued below -249.56, Undervalued between -249.56 and -122.04, Fairly Valued between 132.99 and -122.04, Overvalued between 132.99 and 260.50, and Strongly Overvalued above 260.50. The current Forward P/FCF of 222.73 falls within the Overvalued range.

KORU Medical Systems Inc (KRMD) has a current Price-to-Book (P/B) ratio of 15.49. Compared to its 3-year average P/B ratio of 7.05 , the current P/B ratio is approximately 119.71% higher. Relative to its 5-year average P/B ratio of 5.81, the current P/B ratio is about 166.64% higher. KORU Medical Systems Inc (KRMD) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -2.88%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -3.49% , the current FCF yield is about -100.00% lower.

15.49

P/B

Median3y

7.05

Median5y

5.81

-0.07

FCF Yield

Median3y

-2.88

Median5y

-3.49

Competitors Valuation Multiple

The average P/S ratio for KRMD's competitors is , providing a benchmark for relative valuation. KORU Medical Systems Inc Corp (KRMD) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 27.17%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of KRMD increased by 43.12% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -38.57 to -68.37.

The secondary factor is the Revenue Growth, contributed 27.17%to the performance.

Overall, the performance of KRMD in the past 1 year is driven by P/E Change. Which is more unsustainable.

27.17%

8.18M → 10.40M

Revenue Growth

-61.30%

-19.33 → -7.48

Margin Expansion

77.25%

-38.57 → -68.37

P/E Change

43.12%

3.85 → 5.51

Mkt Cap Growth

People Also Watch

Frequently Asked Questions

Is KORU Medical Systems Inc (KRMD) currently overvalued or undervalued?

What is KORU Medical Systems Inc (KRMD) fair value?

KRMD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of KORU Medical Systems Inc (KRMD) is between NaN to NaN according to relative valuation methord.

How does KRMD's valuation metrics compare to the industry average?

What is the current P/B ratio for KORU Medical Systems Inc (KRMD) as of Dec 18 2025?

As of Dec 18 2025, KORU Medical Systems Inc (KRMD) has a P/B ratio of 15.49. This indicates that the market values KRMD at 15.49 times its book value.

What is the current FCF Yield for KORU Medical Systems Inc (KRMD) as of Dec 18 2025?

As of Dec 18 2025, KORU Medical Systems Inc (KRMD) has a FCF Yield of 0.00%. This means that for every dollar of KORU Medical Systems Inc’s market capitalization, the company generates 0.00 cents in free cash flow.

What is the current Forward P/E ratio for KORU Medical Systems Inc (KRMD) as of Dec 18 2025?

As of Dec 18 2025, KORU Medical Systems Inc (KRMD) has a Forward P/E ratio of -440.80. This means the market is willing to pay $-440.80 for every dollar of KORU Medical Systems Inc’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for KORU Medical Systems Inc (KRMD) as of Dec 18 2025?

As of Dec 18 2025, KORU Medical Systems Inc (KRMD) has a Forward P/S ratio of 0.00. This means the market is valuing KRMD at $0.00 for every dollar of expected revenue over the next 12 months.

KRMD Valuation

Overview

Forecast

Valuation

Earnings